Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 26 Neoplasms 3 Arthralgia 3 Polycystic Ovary Syndrome 2 Neoplasm Metastasis 2 Advanced Breast Cancer 2 Recurrence 1 Pain 1 Osteoporosis 1 Obesity 1 Hypoxia 1 Fractures, Bone 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1 Breast Cancer Organoids 1

Interventions

Blood Specimen Collection 5 Surveys and Questionnaires 3 exemestane 2 Tirzepatide 2 Tamoxifen 2 Observation 2 Esophagectomy 2 Biopsy 2 BaseLine dental cement 2 Bariatric Surgery 2 Anastrozole 2 semaglutide 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Utrogestan 1 Urine Specimen Collection 1 Topiramate 1 Testosterone 1 Stents 1 Qsymia 1 Phentermine 1 Naltrexone 1 Metabolic Networks and Pathways 1 Medical History Taking 1 Mammography 1 Liraglutide 1 Letrozole 1 Hematologic Tests 1 Gonadotropin-Releasing Hormone 1 Glucose Tolerance Test 1 Glucagon-Like Peptide-1 Receptor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Obesity × Letrozole × Clear all

NCT01896050 2016-06-28

LOGRIBMET

University of Michigan Rogel Cancer Center

115 enrolled 14 charts

Breast Neoplasms, Obesity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡